Funding Update
Internal + Extramural Opportunities
Extramural Opportunities
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
- Special Announcement
- Non-Limited Opportunities
- Non-Peer Reviewed Agencies
- Cancer and Aging Research Group (CARG)
- Cancer Research Institute
- Conquer Cancer Foundation / American Society of Clinical Oncology (ASCO)
- Mike Slive Foundation
- Pancreatic Cancer Action Network
- Pfizer
- National Foundation for Cancer Research
Special Announcement
James and Esther King Biomedical Research Program
Application Due: 9/10/2021
Bankhead-Coley Cancer Research Program
Application Due: 9/10/2021
Live Like Bella Pediatric Cancer Research Initiative
Application Due: 9/17/2021
Non-Limited Opportunities
Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
RFA-CA-21-040
Application: 10/1/2021
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
PAR-21-290
Application: 10/5/2021
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
PAR-21-294
Application: 10/5/2021
Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed)
RFA-CA21-022
Application: 10/6/2021
Cancer Target Discovery and Development (CTD2) (U01 Clinical Trial Not Allowed)
PAR-21-274
Application: 10/6/2021
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
RFA-CA-21-038
Application: 10/7/2021
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed)
RFA-CA-21-039
Application: 10/7/2021
The NCI Transition Career Development Award (K22 – Independent Clinical Trial Required)
Application: 10/12/2021
The NCI Transition Career Development Award (K22 – Independent Clinical Trial Not Allowed)
Application: 10/12/2021
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
Application: 10/12/2021
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-20-292
Application: 10/20/2021
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-21-285
Application: 11/1/2021
Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed)
RFA-CA-21-041
Application: 11/1/2021
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
PAR-21-190
Application:11/8/2021
Division of Cancer Biology Multi-Consortia Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-CA-21-049
Application: 11/12/2021
Research Centers for Cancer Systems Biology (U54 Clinical Trial Not Allowed)
RFA-CA-21-048
Application: 11/12/2021
Melanoma Research Program
Discovery Award
Pre-Application: 10/20/2021
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
RFA-HL-22-010
Application: 10/14/2021
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
RFA-HG-21-041
Application: 2/22/2022
Research to Improve Native American Health (R21 Clinical Trials Optional)
PAR-20-2014
Application: 5/17/2022
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
PAR-20-238
Application: 5/17/2022
SPECIAL INITIATIVE: Health Equity Research in Cancer Control and Prevention
Application: 10/15/2021
The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services
Application: 4/1/2022
Team Science Academic-Industry Partnership Award
LOI to Sponsor: 10/6/2021
Team Science Award
LOI to Sponsor: 10/6/2021
Young Investigator Award
Checklist Due: 11/3/2021
Pilot Award
Application: 11/17/2021
Non-Peer Reviewed Agencies
Cancer and Aging Research Group (CARG)
Pre-Clinical & Translational Research in Multiple Myeloma
Application: 9/28/2021
Cancer Research Institute
CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity
Application: 10/1/2021
Clinic & Laboratory Integration Program (CLIP)
LOI Due: 11/1/2021
Conquer Cancer Foundation / American Society of Clinical Oncology (ASCO)
Young Investigator Award
Application: 9/23/2021
Career Development Award
Application: 9/23/2021
Mike Slive Foundation
Mike Slive Foundation for Prostate Cancer Research
Application: 10/1/2021
Pancreatic Cancer Action Network
Career Development Award
Application: 10/25/2021
Pfizer
Best Practices in HR+ HER- Metastatic Breast Cancer Medical Management
Application: 9/22/2021
Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer
Application: 9/27/2021
Pre-clinical & Translational Research in Multiple Myeloma
Application: 9/28/2021
Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support
Application: 10/11/2021
PARP-inhibitor Combination Treatments in Prostate Cancer
Application: 10/13/2021
National Foundation for Cancer Research
Szent-Györgyi Prize for Progress in Cancer Research
Application: 10/15/2021
